FOXO Technologies Inc.’s (OTC: FOXOD/FOXO) ( “FOXO”) subsidiary, Vector BioSource, Inc. (“Vector”) announces that it has entered into a definitive agreement to acquire four U.S.-based blood collection centers (the “Agreement”) from Grifols Bio Supplies, Inc., a U.S.-based subsidiary of Grifols S.A. The acquisition is intended to provide a proprietary source of bio-products to sell to Vector’s customers to augment its existing sourcing model. Furthermore, the new FDA licensure that Vector expects to be required is anticipated to further expand Vector’s accessible market.
Read the full article: FOXO Technologies Inc.’s Subsidiary Vector BioSource, Inc. Enters into Definitive Agreement to Acquire Four Blood Collection Centers from Grifols Bio Supplies, Inc. //
Source: https://www.globenewswire.com/news-release/2026/07/29/3335218/0/en/foxo-technologies-inc-s-subsidiary-vector-biosource-inc-enters-into-definitive-agreement-to-acquire-four-blood-collection-centers-from-grifols-bio-supplies-inc.html